The Central Drugs Standard Control Organization (CDSCO) is inviting stakeholders to provide feedback on Subject Expert Committee (SEC) meetings. This invitation was issued by a public notice dated April 22, 2024. This invitation is open to all stakeholders and Indian drug/ pharmaceuticals associations.
SEC meetings involve discussions on various aspects of drug development and regulation. These committees play a role in the approval process for new drugs or medical devices. The CDSCO aims to improve SEC meetings to better align with stakeholder expectations.
Stakeholder organizations can nominate a representative familiar with the subject matter to attend a consultation meeting:
- Date: April 26, 2024
- Time: 5:00 PM to 6:00 PM
- Location: CDSCO Headquarters (New Delhi)
Organizations should send nominations via email to:
- dci@nic.in and
- expert-committee@cdsco.nic.in
A virtual link for the meeting will be provided to registered participants by email.
